Oscar Health (OSCR) Depreciation & Amortization (CF) (2020 - 2026)

Oscar Health has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $7.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 4.28% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $29.2 million (down 6.04% YoY), and the FY2025 full-year result was $28.9 million, down 10.09% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $7.0 million, down from $7.9 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $9.2 million in Q4 2024, with the low at $3.7 million in Q2 2022.
• Historically, Depreciation & Amortization (CF) has averaged $6.7 million across 5 years, with a median of $7.3 million in 2025.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 139.01% — and 2024, when it declined 18.4%.
• Oscar Health's Depreciation & Amortization (CF) stood at $3.7 million in 2022, then soared by 107.28% to $7.7 million in 2023, then increased by 19.26% to $9.2 million in 2024, then decreased by 14.57% to $7.9 million in 2025, then declined by 11.03% to $7.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $7.0 million (Q1 2026), $7.9 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.